Virginia G Kaklamani Selected Research

Virginia G Kaklamani Research Topics

Disease

38	Breast Neoplasms (Breast Cancer) 11/2023 - 01/2003
20	Neoplasms (Cancer) 08/2023 - 04/2003
5	Triple Negative Breast Neoplasms 11/2023 - 06/2015
3	Obesity 07/2017 - 10/2008
3	Colorectal Neoplasms (Colorectal Cancer) 01/2011 - 09/2003
2	Pathologic Complete Response 11/2023 - 01/2019
2	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 09/2003
1	Genomic Instability 11/2023
1	Circulating Neoplastic Cells 08/2023
1	Nausea 10/2022
1	Chromothripsis 01/2020
1	Second Primary Neoplasms (Neoplasms, Second) 07/2018
1	Weight Gain 07/2017
1	Neoplasm Metastasis (Metastasis) 10/2014
1	Noninfiltrating Intraductal Carcinoma (DCIS) 05/2014
1	Ductal Carcinoma 05/2014
1	Carcinogenesis 01/2012
1	Hyperinsulinism (Hyperinsulinemia) 10/2008
1	Disease Progression 01/2007
1	Brain Neoplasms (Brain Tumor) 04/2006
1	Diarrhea 03/2005
1	Hematologic Neoplasms (Hematological Malignancy) 09/2003
1	Urinary Bladder Neoplasms (Bladder Cancer) 09/2003

Drug/Important Bio-Agent (IBA)

13	Hormones (Hormone)IBA 08/2023 - 01/2005
10	Estrogen ReceptorsIBA 11/2023 - 08/2012
5	ErbB Receptors (EGF Receptor)IBA 10/2022 - 04/2012
5	AdiponectinIBA 06/2013 - 05/2008
4	human ERBB2 proteinIBA 10/2022 - 08/2012
4	Tamoxifen FDA LinkGeneric 07/2021 - 01/2005
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2008
4	Transforming Growth Factor-beta Type I ReceptorIBA 12/2008 - 09/2003
3	elacestrantIBA 08/2023 - 10/2019
3	eribulin FDA Link 01/2021 - 06/2015
3	AnthracyclinesIBA 01/2020 - 04/2003
3	Trastuzumab (Herceptin)FDA Link 01/2019 - 01/2005
3	Transforming Growth Factor beta (TGF-beta)IBA 12/2008 - 08/2004
2	Fulvestrant (Faslodex)FDA Link 08/2023 - 10/2019
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2015
2	Lapatinib (GW572016)FDA Link 01/2019 - 04/2012
2	130-nm albumin-bound paclitaxelIBA 01/2019 - 04/2012
2	LigandsIBA 01/2018 - 08/2004
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 10/2017
2	Estrogens (Estrogen)FDA Link 01/2018 - 01/2017
2	Capecitabine (Xeloda)FDA Link 05/2011 - 04/2003
2	Adiponectin ReceptorsIBA 10/2008 - 05/2008
2	Taxoids (Taxanes)IBA 01/2005 - 01/2003
1	PlatinumIBA 11/2023
1	Nonesterified Fatty Acids (NEFA)IBA 01/2023
1	Cyclin-Dependent Kinase 4IBA 10/2022
1	Medical MarijuanaIBA 01/2022
1	Histone Deacetylase InhibitorsIBA 10/2021
1	sapanisertibIBA 07/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 07/2021
1	B7-H1 AntigenIBA 01/2021
1	pembrolizumabIBA 01/2021
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	taxaneIBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	RAD1901IBA 10/2019
1	Aromatase InhibitorsIBA 10/2019
1	Ado-Trastuzumab EmtansineIBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	pertuzumabIBA 01/2019
1	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2018
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2016
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2016
1	TOR Serine-Threonine KinasesIBA 01/2016
1	ParaffinIBA 11/2015
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2015
1	DNA (Deoxyribonucleic Acid)IBA 06/2015
1	Carboplatin (JM8)FDA LinkGeneric 06/2015
1	Yttrium-90IBA 10/2014
1	Metformin (Glucophage)FDA LinkGeneric 08/2012
1	Progesterone Receptors (Progesterone Receptor)IBA 08/2012
1	Phosphotransferases (Kinase)IBA 04/2012
1	Insulin (Novolin)FDA Link 01/2012
1	LeptinIBA 01/2012
1	ixabepilone (BMS 247550)FDA Link 05/2011
1	Messenger RNA (mRNA)IBA 05/2008
1	Cytotoxins (Cytolysins)IBA 01/2007
1	efaproxiral (RSR-13)IBA 04/2006
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2005
1	Monoclonal AntibodiesIBA 01/2005
1	ErbB-2 ReceptorIBA 01/2005
1	Fluorouracil (Carac)FDA LinkGeneric 04/2003
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2003
1	Antineoplastic Agents (Antineoplastics)IBA 04/2003
1	Epirubicin (Ellence)FDA LinkGeneric 04/2003

Therapy/Procedure

21	Therapeutics 11/2023 - 04/2003
9	Drug Therapy (Chemotherapy) 10/2022 - 03/2005
5	Adjuvant Chemotherapy 01/2020 - 01/2003
3	Neoadjuvant Therapy 07/2021 - 06/2015
3	Radiotherapy 01/2012 - 03/2005
2	Aftercare (After-Treatment) 01/2022 - 07/2017
1	Immunotherapy 01/2021
1	Biological Therapy 01/2007
1	Duration of Therapy 01/2007
1	Chemoprevention 08/2004